|
|
Article: The Motley Fool Selects New Rule Breaker.
- Article from:
- PR Newswire
- Article date:
- September 22, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ALEXANDRIA, Va., Sept. 22 /PRNewswire/ --
The Motley Fool announced yesterday after market close that it plans to add Human Genome Sciences (Nasdaq: HGSI) to its Rule Breaker Portfolio. Headquartered in Rockville, MD, Human Genome Sciences is a biotechnology start-up that creates medicine using the human body's genes, proteins, and antibodies.
Human Genome Sciences will join America Online, Celera, Amazon.com, eBay, Starbucks, Amgen, and Excite@Home in a portfolio that has returned an average of more than 50% per year for a gain of more than 1200% since inception.
"In conjunction with our community of individual investors, we've been examining ...